e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Novel therapies for asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Improving asthma therapy through targeting more effective control of inflammation - a European consensus
S. Holgate, for the European Consensus Conference (Southampton, United Kingdom)
Source:
Annual Congress 2005 - Novel therapies for asthma
Session:
Novel therapies for asthma
Session type:
Poster Discussion
Number:
1724
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Holgate, for the European Consensus Conference (Southampton, United Kingdom). Improving asthma therapy through targeting more effective control of inflammation - a European consensus. Eur Respir J 2005; 26: Suppl. 49, 1724
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012
Combination therapy versus separate therapy in real-life primary care asthma patients
Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care
Year: 2015
Development and evaluation of an educational intervention targeted at optimising adherence with measures to prevent asthma in children with a familial allergic disposition (FOCUS-project)
Source: Eur Respir J 2002; 20: Suppl. 38, 329s
Year: 2002
Small airways targeting of inhaled steroids for severe therapy resistant asthma in children
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
The remarkable role of adherence to inhaled corticosteroids in achieving asthma control in young children with asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
The effectiveness of patient education to improve adherence to the asthma treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
The role of adherence to inhaled corticosteroids (ICS) in the relationship between blood eosinophilia and asthma control
Source: International Congress 2016 – Asthma management in primary care
Year: 2016
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
Impact of educational intervention on inhaler techniques and disease control
Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals
Year: 2013
Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005
Managing asthma patients: which outcomes matter?
Source: Eur Respir Rev 2008; 17: 53-61
Year: 2008
A treatment algorithm adjusting oral corticosteroid using blood eosinophils reduces exacerbations and improves asthma control, in difficult asthmatics
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
The British Lung Foundation asthma management programme - improving asthma control in adults
Source: International Congress 2017 – Improve your competences: new directions from medical education
Year: 2017
The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016
The parameters that may affect inhalation therapy success in elderly COPD and asthma patients
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015
Improving asthma control with therapeutic education intervention
Source: Annual Congress 2011 - Integrated care and telehealth in primary care
Year: 2011
Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Asthma management - The role of drug delivery
Source: Annual Congress 2005 - Asthma management - important issues
Year: 2005
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept